Last --
Change Today 0.00 / 0.00%
Volume 0.0
4506 On Other Exchanges
Symbol
Exchange
4506 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Chiang J. Li M.D., FACP.

Head of Global Oncology and Executive Officer, Dainippon Sumitomo Pharma Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 3 different organizations across 6 different industries.

See Board Relationships
48--

Background*

Dr. Chiang J. Li, Ph.D., M.D serves as the President, Chief Executive Officer and Chief Medical Officer at Boston Biomedical, Inc. (BBI). Dr. Li serves as an Executive Officer and Head of Global Oncology of Dainippon Sumitomo Pharma Co., Ltd. He is a Founder of Cequent Pharmaceuticals, Inc. He serves as Head of Global Oncology at the DSP Group. Dr. Li served as the Chief Scientific Officer of Boston Biomedical, Inc. which he founded it in November 2006. He served as ...

Read Full Background

Corporate Headquarters*

6-8 Doshomachi 2-chome
Osaka, -- 541-0045

Japan

Phone: 81 6 6203 5321
Fax: 81 6 6202 6028

Board Members Memberships*

Founder, Chairman of the Scientific Advisory Board and Director
Founder, Chief Executive Officer, President, Chief Medical Officer and Director
2010-2011
Former Scientific Advisor and Director

Education*

MD
Harvard Medical School
Unknown/Other Education
Harvard-MIT Division of Health Sciences and Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4506:JP ¥1,603.00 JPY -28.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey J. Clarke Chief Executive Officer and Director
Eastman Kodak Co.
--
William S. Marth Chief Executive Officer, President, Director and Member of Audit Committee
Albany Molecular Research Inc.
--
Thomas Kyle Hall Chief Executive Officer and Director
PNI Digital Media Inc.
C$265.0K
Justin Korteasa Interim Managing Director
GlaxoSmithKline Consumer Nigeria Plc
--
Mihael H. Polymeropoulos M.D.Founder, Chief Executive Officer, President and Director
Vanda Pharmaceuticals, Inc.
$515.0K
Compensation as of Fiscal Year --.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAINIPPON SUMITOMO PHARMA CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.